{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:43:42Z","timestamp":1782791022927,"version":"3.54.5"},"reference-count":141,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["F31DK131914"],"award-info":[{"award-number":["F31DK131914"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01DK125459"],"award-info":[{"award-number":["R01DK125459"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01HL145528"],"award-info":[{"award-number":["R01HL145528"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01DK136679"],"award-info":[{"award-number":["R01DK136679"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R56DK104753"],"award-info":[{"award-number":["R56DK104753"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UE5DK137308"],"award-info":[{"award-number":["UE5DK137308"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U54DK083912"],"award-info":[{"award-number":["U54DK083912"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U24DK100845"],"award-info":[{"award-number":["U24DK100845"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U01DK116101"],"award-info":[{"award-number":["U01DK116101"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["24PRE1242192"],"award-info":[{"award-number":["24PRE1242192"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019337","name":"Miami Clinical Translational Science Institute","doi-asserted-by":"publisher","award":["UM1TR004556"],"award-info":[{"award-number":["UM1TR004556"]}],"id":[{"id":"10.13039\/100019337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and hypothesis<\/jats:title>\n                    <jats:p>Patients with nephrotic syndrome develop albuminuria, hyperlipidemia, and heart failure, but the pathomechanisms underlying this interconnection are unclear. We previously found that fibroblast growth factor 23 (FGF23) promotes cardiac hypertrophy in animal models of chronic kidney disease (CKD). Since patients with nephrotic syndrome have elevated FGF23, we hypothesized that FGF23 also contributes to heart damage in nephrotic syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We previously developed a mouse model with the inducible and podocyte-specific overexpression of a constitutively active NFATc1 mutant variant (NFATc1nuc), which within 1 week develops a nephrotic syndrome-like phenotype. Here, we conducted serological analyses of phosphate and lipid metabolism, and we studied the cardiac phenotype after 1 week and 3 months of albuminuria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After 1 week, mice presented with albuminuria, hyperlipidemia, and elevated serum FGF23 levels, as well as reductions in cardiac function and cardiac hypertrophy on a cellular level without significant increases in cardiac mass or fibrosis. Under physiologic conditions and in CKD, elevations in systemic phosphate levels, also called hyperphosphatemia, induce FGF23 production in the bone. However, in NFATc1nuc mice we could detect neither increases in serum phosphate levels nor in FGF23 expression in the bone. Instead, nephrotic mice had FGF23 elevations in the heart, and our in vitro studies showed that free fatty acids induced FGF23 expression in cardiac myocytes resulting in hypertrophy. We also found that mice with prolonged NFATc1nuc expression transition into a CKD-like phenotype with hyperphosphatemia and further FGF23 elevations, as well as cardiac hypertrophy and fibrosis and a reduced lifespan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study suggests that NFATc1nuc mice serve as a model of nephrotic syndrome that progresses to CKD with pathologic cardiac remodeling. Our findings indicate that hyperlipidemia might contribute to heart failure in nephrotic syndrome by inducing FGF23 expression in the heart, which then drives cardiac hypertrophy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfaf272","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:35:02Z","timestamp":1766406902000},"page":"1340-1356","source":"Crossref","is-referenced-by-count":1,"title":["Nephrotic syndrome in mice elevates FGF23 levels and leads to cardiac hypertrophy in the absence of hyperphosphatemia"],"prefix":"10.1093","volume":"41","author":[{"given":"Abul","family":"Fajol","sequence":"first","affiliation":[{"name":"The University of Alabama at Birmingham Section of Mineral Metabolism, Division of Nephrology, Department of Medicine, Heersink School of Medicine, , Birmingham, AL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[{"name":"The University of Alabama at Birmingham Section of Mineral Metabolism, Division of Nephrology, Department of Medicine, Heersink School of Medicine, , Birmingham, AL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Madison","family":"Thomas","sequence":"additional","affiliation":[{"name":"The University of Alabama at Birmingham Section of Mineral Metabolism, Division of Nephrology, Department of Medicine, Heersink School of Medicine, , Birmingham, AL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Sloan","sequence":"additional","affiliation":[{"name":"Peggy and Harold Katz Family Drug Discovery Center, and University of Miami Miller School of Medicine Katz Family Division of Nephrology and Hypertension, Department of Medicine, and , Miami, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihao","family":"He","sequence":"additional","affiliation":[{"name":"The University of Alabama at Birmingham Division of Cardiovascular Disease, Department of Medicine, Heersink School of Medicine, , Birmingham, AL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xie","sequence":"additional","affiliation":[{"name":"The University of Alabama at Birmingham Division of Cardiovascular Disease, Department of Medicine, Heersink School of Medicine, , Birmingham, AL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Heitman","sequence":"additional","affiliation":[{"name":"The University of Alabama at Birmingham Section of Mineral Metabolism, Division of Nephrology, Department of Medicine, Heersink School of Medicine, , Birmingham, AL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Kentrup","sequence":"additional","affiliation":[{"name":"The University of Alabama at Birmingham Section of Mineral Metabolism, Division of Nephrology, Department of Medicine, Heersink School of Medicine, , Birmingham, AL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Yanucil","sequence":"additional","affiliation":[{"name":"The University of Alabama at Birmingham Section of Mineral Metabolism, Division of Nephrology, Department of Medicine, Heersink School of Medicine, , Birmingham, AL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Grabner","sequence":"additional","affiliation":[{"name":"Peggy and Harold Katz Family Drug Discovery Center, and University of Miami Miller School of Medicine Katz Family Division of Nephrology and Hypertension, Department of Medicine, and , Miami, FL ,","place":["USA"]},{"name":"University Medical Center Hamburg-Eppendorf Division of Nephrology, Department of Medicine, , Hamburg ,","place":["Germany"]},{"name":"Hamburg Center for Kidney Health (HCKH), University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Merscher","sequence":"additional","affiliation":[{"name":"Peggy and Harold Katz Family Drug Discovery Center, and University of Miami Miller School of Medicine Katz Family Division of Nephrology and Hypertension, Department of Medicine, and , Miami, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Fornoni","sequence":"additional","affiliation":[{"name":"Peggy and Harold Katz Family Drug Discovery Center, and University of Miami Miller School of Medicine Katz Family Division of Nephrology and Hypertension, Department of Medicine, and , Miami, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando M","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"The University of Alabama at Birmingham Section of Mineral Metabolism, Division of Nephrology, Department of Medicine, Heersink School of Medicine, , Birmingham, AL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7512-0977","authenticated-orcid":false,"given":"Christian","family":"Faul","sequence":"additional","affiliation":[{"name":"The University of Alabama at Birmingham Section of Mineral Metabolism, Division of Nephrology, Department of Medicine, Heersink School of Medicine, , Birmingham, AL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"2026062922460912500_bib1","doi-asserted-by":"publisher","first-page":"17088","DOI":"10.1038\/nrdp.2017.88","article-title":"Chronic kidney disease","volume":"3","author":"Romagnani","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2026062922460912500_bib2","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2026062922460912500_bib3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/jcm7120493","article-title":"The number of comorbidities predicts renal outcomes in patients with stage 3(-)5 chronic kidney disease","volume":"7","author":"Lee","year":"2018","journal-title":"J Clin Med"},{"key":"2026062922460912500_bib4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"2026062922460912500_bib5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Evolving importance of kidney disease: from subspecialty to global health burden","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet"},{"key":"2026062922460912500_bib6","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"2026062922460912500_bib7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1172\/JCI62839","article-title":"Signaling effectors underlying pathologic growth and remodeling of the heart","volume":"123","author":"van Berlo","year":"2013","journal-title":"J Clin Invest"},{"key":"2026062922460912500_bib8","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/01.ASN.0000117977.14912.91","article-title":"Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients","volume":"15","author":"Zoccali","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2026062922460912500_bib9","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N Engl J Med"},{"key":"2026062922460912500_bib10","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/ndt\/gfz232","article-title":"Sudden cardiac death in chronic renal disease: aetiology and risk reduction strategies","volume":"36","author":"Pickup","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922460912500_bib11","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1056\/NEJMoa0910975","article-title":"Intensive blood-pressure control in hypertensive chronic kidney disease","volume":"363","author":"Appel","year":"2010","journal-title":"N Engl J Med"},{"key":"2026062922460912500_bib12","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2011.861","article-title":"Temporal trends in the prevalence of diabetic kidney disease in the United States","volume":"305","author":"de Boer","year":"2011","journal-title":"JAMA"},{"key":"2026062922460912500_bib13","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"2026062922460912500_bib14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1042\/CS20100377","article-title":"Phosphate toxicity: new insights into an old problem","volume":"120","author":"Razzaque","year":"2011","journal-title":"Clin Sci"},{"key":"2026062922460912500_bib15","doi-asserted-by":"publisher","first-page":"F643","DOI":"10.1152\/ajprenal.00228.2007","article-title":"Phosphate transporters: a tale of two solute carrier families","volume":"293","author":"Virkki","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026062922460912500_bib16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41574-018-0076-3","article-title":"Role of phosphate sensing in bone and mineral metabolism","volume":"14","author":"Chande","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2026062922460912500_bib17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2016.03.039","article-title":"Phosphate\u2014a poison for humans?","volume":"90","author":"Komaba","year":"2016","journal-title":"Kidney Int"},{"key":"2026062922460912500_bib18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrneph.2016.164","article-title":"The role of phosphate in kidney disease","volume":"13","author":"Vervloet","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2026062922460912500_bib19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int"},{"key":"2026062922460912500_bib20","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"2026062922460912500_bib21","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"2026062922460912500_bib22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1681\/ASN.2017070772","article-title":"Longitudinal FGF23 trajectories and mortality in patients with CKD","volume":"29","author":"Isakova","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2026062922460912500_bib23","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2215\/CJN.11901115","article-title":"Phosphate toxicity in CKD: the killer among us","volume":"11","author":"Ritter","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026062922460912500_bib24","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2026062922460912500_bib25","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO4, Ca \u00d7 PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2026062922460912500_bib26","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"2026062922460912500_bib27","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"2026062922460912500_bib28","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","article-title":"FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment","volume":"25","author":"Seiler","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922460912500_bib29","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2026062922460912500_bib30","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"2026062922460912500_bib31","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/MAJ.0b013e3181815498","article-title":"Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients","volume":"337","author":"Hsu","year":"2009","journal-title":"Am J Med Sci"},{"key":"2026062922460912500_bib32","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/ndt\/gfq539","article-title":"Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients","volume":"26","author":"Kirkpantur","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922460912500_bib33","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s00467-012-2224-7","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis","volume":"27","author":"Seeherunvong","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"2026062922460912500_bib34","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"key":"2026062922460912500_bib35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.yjmcc.2019.11.149","article-title":"FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice","volume":"138","author":"Han","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"2026062922460912500_bib36","doi-asserted-by":"publisher","first-page":"e132820","DOI":"10.1172\/jci.insight.132820","article-title":"FGF23 expression is stimulated in transgenic alpha-Klotho longevity mouse model","volume":"4","author":"Xiao","year":"2019","journal-title":"JCI Insight"},{"key":"2026062922460912500_bib37","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1038\/s41598-017-02068-6","article-title":"FGF23\/FGFR4-mediated left ventricular hypertrophy is reversible","volume":"7","author":"Grabner","year":"2017","journal-title":"Sci Rep"},{"key":"2026062922460912500_bib38","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1093\/ndt\/gfu190","article-title":"Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD","volume":"29","author":"Di Marco","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922460912500_bib39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","article-title":"Idiopathic nephrotic syndrome in children","volume":"392","author":"Noone","year":"2018","journal-title":"Lancet"},{"key":"2026062922460912500_bib40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2026062922460912500_bib41","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1681\/ASN.2016101121","article-title":"Long-term outcome of steroid-resistant nephrotic syndrome in children","volume":"28","author":"Trautmann","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2026062922460912500_bib42","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00467-009-1138-5","article-title":"Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study","volume":"24","author":"Mekahli","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"2026062922460912500_bib43","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1681\/ASN.0000000610","article-title":"Long-term outcomes in nephrotic syndrome by kidney biopsy diagnosis and proteinuria","volume":"36","author":"Pitcher","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"2026062922460912500_bib44","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/ki.1993.292","article-title":"The increased risk of coronary heart disease associated with nephrotic syndrome","volume":"44","author":"Ordonez","year":"1993","journal-title":"Kidney Int"},{"key":"2026062922460912500_bib45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1046\/j.1523-1755.2001.00785.x","article-title":"Vascular function of the peripheral circulation in patients with nephrosis","volume":"60","author":"Watts","year":"2001","journal-title":"Kidney Int"},{"key":"2026062922460912500_bib46","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1093\/ndt\/17.12.2220","article-title":"Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome","volume":"17","author":"Dogra","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922460912500_bib47","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00467-003-1396-6","article-title":"Cardiac disease in children with primary glomerular disorders-role of focal segmental glomerulosclerosis","volume":"19","author":"Adedoyin","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"2026062922460912500_bib48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3389\/fped.2019.00287","article-title":"Hypertension in childhood nephrotic syndrome","volume":"7","author":"Shatat","year":"2019","journal-title":"Front Pediatr"},{"key":"2026062922460912500_bib49","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1007\/s00467-006-0195-2","article-title":"Hyperphosphatemia is prevalent among children with nephrotic syndrome and normal renal function","volume":"21","author":"Feinstein","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"2026062922460912500_bib50","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/nep.13001","article-title":"Fibroblast growth factor 23 in untreated nephrotic syndrome","volume":"23","author":"Yadav","year":"2018","journal-title":"Nephrology"},{"key":"2026062922460912500_bib51","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3892\/etm.2023.12089","article-title":"Significance of changes in FGF23 levels in childhood primary nephrotic syndrome and children who progress to end\u2011stage renal disease","volume":"26","author":"Liu","year":"2023","journal-title":"Exp Ther Med"},{"key":"2026062922460912500_bib52","doi-asserted-by":"publisher","first-page":"9698367","DOI":"10.1155\/2019\/9698367","article-title":"Assessment of the concentration of bone metabolism markers: sclerostin and FGF-23 in children with idiopathic nephrotic syndrome treated with glucocorticosteroids","volume":"2019","author":"Pukajlo-Marczyk","year":"2019","journal-title":"Dis Markers"},{"key":"2026062922460912500_bib53","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.10331011","article-title":"FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy","volume":"7","author":"Lundberg","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026062922460912500_bib54","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2215\/CJN.05840513","article-title":"Disordered FGF23 and mineral metabolism in children with CKD","volume":"9","author":"Portale","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026062922460912500_bib55","doi-asserted-by":"publisher","first-page":"e030131","DOI":"10.1161\/JAHA.123.030131","article-title":"Albuminuria: an underappreciated risk factor for cardiovascular disease","volume":"13","author":"Barzilay","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026062922460912500_bib56","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1681\/ASN.2014010104","article-title":"Proteinuria increases plasma phosphate by altering its tubular handling","volume":"26","author":"de Seigneux","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2026062922460912500_bib57","doi-asserted-by":"publisher","first-page":"3609645","DOI":"10.1155\/2018\/3609645","article-title":"Calcitriol prevents cardiovascular repercussions in puromycin aminonucleoside-induced nephrotic syndrome","volume":"2018","author":"Catia","year":"2018","journal-title":"Biomed Res Int"},{"key":"2026062922460912500_bib58","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/sj.ki.5002204","article-title":"Cardiac remodeling and dysfunction in nephrotic syndrome","volume":"71","author":"Moreira-Rodrigues","year":"2007","journal-title":"Kidney Int"},{"key":"2026062922460912500_bib59","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1096\/fj.201900893R","article-title":"Klotho regulation by albuminuria is dependent on ATF3 and endoplasmic reticulum stress","volume":"34","author":"Delitsikou","year":"2020","journal-title":"FASEB J"},{"key":"2026062922460912500_bib60","doi-asserted-by":"publisher","first-page":"e95091","DOI":"10.1172\/jci.insight.95091","article-title":"Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities","volume":"3","author":"Christov","year":"2018","journal-title":"JCI Insight"},{"key":"2026062922460912500_bib61","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000497118","article-title":"The role of extracellular phosphate levels on kidney disease progression in a podocyte injury mouse model","volume":"142","author":"Maeda","year":"2019","journal-title":"Nephron"},{"key":"2026062922460912500_bib62","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.ajpath.2011.06.033","article-title":"Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway","volume":"179","author":"Nijenhuis","year":"2011","journal-title":"Am J Pathol"},{"key":"2026062922460912500_bib63","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1172\/JCI85939","article-title":"Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury","volume":"126","author":"Pedigo","year":"2016","journal-title":"J Clin Invest"},{"key":"2026062922460912500_bib64","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1101\/gad.11.7.824","article-title":"Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction","volume":"11","author":"Beals","year":"1997","journal-title":"Genes Dev"},{"key":"2026062922460912500_bib65","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.devcel.2006.04.006","article-title":"Calcineurin\/NFAT signaling in osteoblasts regulates bone mass","volume":"10","author":"Winslow","year":"2006","journal-title":"Dev Cell"},{"key":"2026062922460912500_bib66","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1681\/ASN.V1481998","article-title":"Inducible podocyte-specific gene expression in transgenic mice","volume":"14","author":"Shigehara","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2026062922460912500_bib67","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"key":"2026062922460912500_bib68","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrneph.2017.155","article-title":"Dyslipidaemia in nephrotic syndrome: mechanisms and treatment","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"2026062922460912500_bib69","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41387-018-0037-x","article-title":"A high-fat diet stimulates fibroblast growth factor 23 formation in mice through TNFalpha upregulation","volume":"8","author":"Glosse","year":"2018","journal-title":"Nutr Diabetes"},{"key":"2026062922460912500_bib70","doi-asserted-by":"publisher","first-page":"36881","DOI":"10.1038\/srep36881","article-title":"Energy-dense diets increase FGF23, lead to phosphorus retention and promote vascular calcifications in rats","volume":"6","author":"Raya","year":"2016","journal-title":"Sci Rep"},{"key":"2026062922460912500_bib71","doi-asserted-by":"publisher","first-page":"e0198481","DOI":"10.1371\/journal.pone.0198481","article-title":"Phosphorus restriction does not prevent the increase in fibroblast growth factor 23 elicited by high fat diet","volume":"13","author":"Rios","year":"2018","journal-title":"PLoS ONE"},{"key":"2026062922460912500_bib72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2014.10.002","article-title":"Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-kappaB both in vitro and in vivo","volume":"79","author":"Zeng","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"2026062922460912500_bib73","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbalip.2010.11.002","article-title":"PPARbeta\/delta activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells","volume":"1811","author":"Alvarez-Guardia","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"2026062922460912500_bib74","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1530\/JME-15-0155","article-title":"GLP1 protects cardiomyocytes from palmitate-induced apoptosis via Akt\/GSK3b\/b-catenin pathway","volume":"55","author":"Ying","year":"2015","journal-title":"J Mol Endocrinol"},{"key":"2026062922460912500_bib75","doi-asserted-by":"publisher","first-page":"13997","DOI":"10.1038\/ncomms13997","article-title":"Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2","volume":"8","author":"Wang","year":"2017","journal-title":"Nat Commun"},{"key":"2026062922460912500_bib76","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/jcp.30922","article-title":"Palmitic acid methyl ester induces cardiac hypertrophy through activating the GPR receptor-mediated changes of intracellular calcium concentrations and mitochondrial functions","volume":"238","author":"Lien","year":"2023","journal-title":"J Cell Physiol"},{"key":"2026062922460912500_bib77","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M23-2814","article-title":"Association of albuminuria with chronic kidney disease progression in persons with chronic kidney disease and normoalbuminuria: a cohort study","volume":"177","author":"Verma","year":"2024","journal-title":"Ann Intern Med"},{"key":"2026062922460912500_bib78","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1681\/ASN.0000000000000357","article-title":"Spatiotemporal landscape of kidney tubular responses to glomerular proteinuria","volume":"35","author":"Faivre","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2026062922460912500_bib79","doi-asserted-by":"publisher","first-page":"e72344","DOI":"10.1371\/journal.pone.0072344","article-title":"Involvement of endoplasmic reticulum stress in albuminuria induced inflammasome activation in renal proximal tubular cells","volume":"8","author":"Fang","year":"2013","journal-title":"PLoS ONE"},{"key":"2026062922460912500_bib80","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/sj.ki.5001704","article-title":"Albumin induces endoplasmic reticulum stress and apoptosis in renal proximal tubular cells","volume":"70","author":"Ohse","year":"2006","journal-title":"Kidney Int"},{"key":"2026062922460912500_bib81","doi-asserted-by":"publisher","first-page":"e14263","DOI":"10.1111\/apha.14263","article-title":"Proteinuria and tubular cells: plasticity and toxicity","volume":"241","author":"Faivre","year":"2025","journal-title":"Acta Physiol"},{"key":"2026062922460912500_bib82","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"2026062922460912500_bib83","doi-asserted-by":"publisher","first-page":"e65597","DOI":"10.1371\/journal.pone.0065597","article-title":"Low-grade albuminuria is associated with metabolic syndrome and its components in middle-aged and elderly Chinese population","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE"},{"key":"2026062922460912500_bib84","doi-asserted-by":"publisher","first-page":"e0118866","DOI":"10.1371\/journal.pone.0118866","article-title":"Association between low-grade albuminuria and cardiovascular risk in Korean adults: the 2011-2012 Korea National Health and Nutrition Examination Survey","volume":"10","author":"Hong","year":"2015","journal-title":"PLoS ONE"},{"key":"2026062922460912500_bib85","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00392-007-0510-3","article-title":"Low-grade albuminuria and cardiovascular risk : what is the evidence?","volume":"96","author":"Schmieder","year":"2007","journal-title":"Clin Res Cardiol"},{"key":"2026062922460912500_bib86","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Chronic Kidney Disease Prognosis C","year":"2010","journal-title":"Lancet"},{"key":"2026062922460912500_bib87","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ki.2010.536","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts","volume":"79","author":"van der Velde","year":"2011","journal-title":"Kidney Int"},{"key":"2026062922460912500_bib88","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ahj.2010.05.022","article-title":"Serum albumin concentration and heart failure risk the health, aging, and body composition study","volume":"160","author":"Gopal","year":"2010","journal-title":"Am Heart J"},{"key":"2026062922460912500_bib89","doi-asserted-by":"publisher","first-page":"w14509","DOI":"10.4414\/smw.2017.14509","article-title":"On the relationship between proteinuria and plasma phosphate","volume":"147","author":"de Seigneux","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"2026062922460912500_bib90","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1093\/ndt\/gfx376","article-title":"Albumin downregulates Klotho in tubular cells","volume":"33","author":"Fernandez-Fernandez","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922460912500_bib91","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/ndt\/gfu291","article-title":"The demonstration of alphaKlotho deficiency in human chronic kidney disease with a novel synthetic antibody","volume":"30","author":"Barker","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922460912500_bib92","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1681\/ASN.2010101073","article-title":"The inflammatory cytokines TWEAK and TNFalpha reduce renal klotho expression through NFkappaB","volume":"22","author":"Moreno","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2026062922460912500_bib93","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1053\/j.gastro.2009.12.002","article-title":"Tumor necrosis factor and interferon-gamma down-regulate Klotho in mice with colitis","volume":"138","author":"Thurston","year":"2010","journal-title":"Gastroenterology"},{"key":"2026062922460912500_bib94","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/ndt\/gfq537","article-title":"Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy","volume":"26","author":"Yoon","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922460912500_bib95","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1161\/01.HYP.0000013734.33441.EA","article-title":"In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage","volume":"39","author":"Mitani","year":"2002","journal-title":"Hypertension"},{"key":"2026062922460912500_bib96","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3389\/fphys.2018.01033","article-title":"Klotho and PPAR gamma activation mediate the renoprotective effect of Losartan in the 5\/6 nephrectomy model","volume":"9","author":"Maquigussa","year":"2018","journal-title":"Front Physiol"},{"key":"2026062922460912500_bib97","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/ndt\/gfy403","article-title":"The effect of interactions between proteinuria, activity of fibroblast growth factor 23 and serum phosphate on renal progression in patients with chronic kidney disease: a result from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease study","volume":"35","author":"Kim","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922460912500_bib98","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1101\/gad.10.23.2981","article-title":"Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome","volume":"10","author":"Cosgrove","year":"1996","journal-title":"Genes Dev"},{"key":"2026062922460912500_bib99","doi-asserted-by":"publisher","first-page":"F120","DOI":"10.1152\/ajprenal.00456.2015","article-title":"Albumin contributes to kidney disease progression in Alport syndrome","volume":"311","author":"Jarad","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026062922460912500_bib100","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/nep.13266","article-title":"FGF-23 in untreated nephrotic syndrome and effects of the renin-angiotensin-aldosterone system","volume":"24","author":"Pazianas","year":"2019","journal-title":"Nephrology"},{"key":"2026062922460912500_bib101","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1161\/ATVBAHA.123.319198","article-title":"Phosphate in cardiovascular disease: from new insights into molecular mechanisms to clinical implications","volume":"44","author":"Turner","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026062922460912500_bib102","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/ki.2011.431","article-title":"Vitamin D deficiency is common in children and adolescents with chronic kidney disease","volume":"81","author":"Kalkwarf","year":"2012","journal-title":"Kidney Int"},{"key":"2026062922460912500_bib103","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s00467-013-2493-9","article-title":"Vitamin D bioavailability and catabolism in pediatric chronic kidney disease","volume":"28","author":"Denburg","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"2026062922460912500_bib104","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(77)92498-9","article-title":"Vitamin-D metabolism in nephrotic syndrome","volume":"2","author":"Barragry","year":"1977","journal-title":"Lancet"},{"key":"2026062922460912500_bib105","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works","volume":"18","author":"Liu","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2026062922460912500_bib106","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/ndt\/gfw454","article-title":"Vitamin D treatment attenuates cardiac FGF23\/FGFR4 signaling and hypertrophy in uremic rats","volume":"32","author":"Leifheit-Nestler","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922460912500_bib107","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/ajh\/hpt177","article-title":"Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats","volume":"27","author":"Freundlich","year":"2014","journal-title":"Am J Hypertens"},{"key":"2026062922460912500_bib108","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.3390\/biomedicines12081860","article-title":"Endocrine disorders in nephrotic syndrome\u2014a comprehensive review","volume":"12","author":"Mizdrak","year":"2024","journal-title":"Biomedicines"},{"key":"2026062922460912500_bib109","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0008-6363(97)00194-6","article-title":"Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide","volume":"37","author":"Schluter","year":"1998","journal-title":"Cardiovasc Res"},{"key":"2026062922460912500_bib110","first-page":"421","article-title":"Serum ionized calcium in nephrotic syndrome","volume":"45","author":"Lim","year":"1976","journal-title":"Q J Med"},{"key":"2026062922460912500_bib111","doi-asserted-by":"publisher","first-page":"101480","DOI":"10.1016\/j.molmet.2022.101480","article-title":"Parathyroid hormone (PTH) regulation of metabolic homeostasis: an old dog teaches us new tricks","volume":"60","author":"Rendina-Ruedy","year":"2022","journal-title":"Mol Metab"},{"key":"2026062922460912500_bib112","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","article-title":"Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences","volume":"90","author":"Vaziri","year":"2016","journal-title":"Kidney Int"},{"key":"2026062922460912500_bib113","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/ATVBAHA.110.214619","article-title":"Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals","volume":"31","author":"Mirza","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026062922460912500_bib114","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000346941","article-title":"Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23","volume":"37","author":"Montford","year":"2013","journal-title":"Am J Nephrol"},{"key":"2026062922460912500_bib115","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/endocr\/bqae141","article-title":"Targeted deletion of fibroblast growth factor 23 rescues metabolic dysregulation of diet-induced obesity in female mice","volume":"165","author":"Park","year":"2024","journal-title":"Endocrinology"},{"key":"2026062922460912500_bib116","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/s41366-025-01808-3","article-title":"High fat diet induces gastric production of fibroblast growth factor 23 (FGF23)","volume":"49","author":"Widmayer","year":"2025","journal-title":"Int J Obes"},{"key":"2026062922460912500_bib117","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1172\/JCI131190","article-title":"Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney","volume":"130","author":"Simic","year":"2020","journal-title":"J Clin Invest"},{"key":"2026062922460912500_bib118","doi-asserted-by":"publisher","first-page":"e164610","DOI":"10.1172\/JCI164610","article-title":"Kidney glycolysis serves as a mammalian phosphate sensor that maintains phosphate homeostasis","volume":"133","author":"Zhou","year":"2023","journal-title":"J Clin Invest"},{"key":"2026062922460912500_bib119","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.kint.2025.01.024","article-title":"Fibroblast Growth Factor (FGF) 23 and FGF Receptor 4 promote cardiac metabolic remodeling in chronic kidney disease","volume":"107","author":"Fuchs","year":"2025","journal-title":"Kidney Int"},{"key":"2026062922460912500_bib120","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fendo.2018.00189","article-title":"FGF23 Actions on target tissues-with and without Klotho","volume-title":"Front Endocrinol","author":"Richter","year":"2018"},{"key":"2026062922460912500_bib121","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1002\/jbmr.2527","article-title":"Experimental myocardial infarction upregulates circulating fibroblast growth factor-23","volume":"30","author":"Andrukhova","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2026062922460912500_bib122","doi-asserted-by":"publisher","first-page":"11298","DOI":"10.1038\/s41598-017-10140-4","article-title":"Genetic ablation of Fgf23 or Klotho does not modulate experimental heart hypertrophy induced by pressure overload","volume":"7","author":"Slavic","year":"2017","journal-title":"Sci Rep"},{"key":"2026062922460912500_bib123","doi-asserted-by":"publisher","first-page":"791479","DOI":"10.3389\/fcell.2021.791479","article-title":"Comprehensive expression analysis of cardiac fibroblast growth factor 23 in health and pressure-induced cardiac hypertrophy","volume":"9","author":"Eitner","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026062922460912500_bib124","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.kint.2018.02.018","article-title":"Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23","volume":"94","author":"Matsui","year":"2018","journal-title":"Kidney Int"},{"key":"2026062922460912500_bib125","doi-asserted-by":"publisher","first-page":"64649","DOI":"10.18632\/oncotarget.11623","article-title":"FGF23 promotes myocardial fibrosis in mice through activation of beta-catenin","volume":"7","author":"Hao","year":"2016","journal-title":"Oncotarget"},{"key":"2026062922460912500_bib126","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.carpath.2019.02.001","article-title":"Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction","volume":"40","author":"Schumacher","year":"2019","journal-title":"Cardiovasc Pathol"},{"key":"2026062922460912500_bib127","first-page":"1055","article-title":"Cardiac fibroblasts produce fibroblast growth factor 23 in response to hyperphosphatemia","volume":"10","author":"Campos","year":"2024","journal-title":"J Cardiovasc Disord"},{"key":"2026062922460912500_bib128","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1038\/s41598-017-02709-w","article-title":"FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts","volume":"7","author":"Smith","year":"2017","journal-title":"Sci Rep"},{"key":"2026062922460912500_bib129","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biocel.2017.09.009","article-title":"FGF23 activates injury-primed renal fibroblasts via FGFR4-dependent signalling and enhancement of TGF-beta autoinduction","volume":"92","author":"Smith","year":"2017","journal-title":"Int J Biochem Cell Biol"},{"key":"2026062922460912500_bib130","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.kint.2017.01.015","article-title":"Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia","volume":"92","author":"Mace","year":"2017","journal-title":"Kidney Int"},{"key":"2026062922460912500_bib131","doi-asserted-by":"publisher","first-page":"e70775","DOI":"10.1371\/journal.pone.0070775","article-title":"Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitor","volume":"8","author":"Zanchi","year":"2013","journal-title":"PLoS ONE"},{"key":"2026062922460912500_bib132","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/ki.2013.526","article-title":"Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease","volume":"85","author":"Spichtig","year":"2014","journal-title":"Kidney Int"},{"key":"2026062922460912500_bib133","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1093\/ndt\/gfaf118","article-title":"Kidney function and mortality in childhood nephrotic syndrome","volume":"40","author":"Robinson","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026062922460912500_bib134","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12098-016-2207-y","article-title":"Ambulatory blood pressure monitoring in frequently relapsing nephrotic syndrome","volume":"84","author":"Sarkar","year":"2017","journal-title":"Indian J Pediatr"},{"key":"2026062922460912500_bib135","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ame2.12249","article-title":"Combined superposition effect of hypertension and dyslipidemia on left ventricular hypertrophy","volume":"5","author":"Zhang","year":"2022","journal-title":"Animal Model Exp Med"},{"key":"2026062922460912500_bib136","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/HYPERTENSIONAHA.119.14167","article-title":"Oleic acid attenuates Ang II (Angiotensin II)-induced cardiac remodeling by inhibiting FGF23 (Fibroblast Growth Factor 23) expression in mice","volume":"75","author":"Liu","year":"2020","journal-title":"Hypertension"},{"key":"2026062922460912500_bib137","doi-asserted-by":"publisher","first-page":"e15323","DOI":"10.1111\/ped.15323","article-title":"Epicardial adipose tissue and risk of arrhythmia in nephrotic syndrome","volume":"64","author":"Simsek","year":"2022","journal-title":"Pediatr Int"},{"key":"2026062922460912500_bib138","doi-asserted-by":"publisher","first-page":"640814","DOI":"10.3389\/fmed.2021.640814","article-title":"Cardiorenal fat: a cardiovascular risk factor with implications in chronic kidney disease","volume":"8","author":"D\u2019Marco","year":"2021","journal-title":"Front Med"},{"key":"2026062922460912500_bib139","doi-asserted-by":"publisher","first-page":"5156","DOI":"10.1182\/bloodadvances.2022009524","article-title":"Bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in a mouse model of iron deficiency anemia","volume":"7","author":"Li","year":"2023","journal-title":"Blood Adv"},{"key":"2026062922460912500_bib140","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s44324-025-00087-w","article-title":"Deletion of cardiac fibroblast growth factor-23 beneficially impacts myocardial energy metabolism in left ventricular hypertrophy","volume":"3","author":"Latic","year":"2025","journal-title":"NPJ Metab Health Dis"},{"key":"2026062922460912500_bib141","doi-asserted-by":"publisher","first-page":"745892","DOI":"10.3389\/fcell.2021.745892","article-title":"Cardiac fibroblast growth factor 23 excess does not induce left ventricular hypertrophy in healthy mice","volume":"9","author":"Leifheit-Nestler","year":"2021","journal-title":"Front Cell Dev Biol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfaf272\/66098253\/gfaf272.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/7\/1340\/66098253\/gfaf272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/7\/1340\/66098253\/gfaf272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:46:16Z","timestamp":1782787576000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/7\/1340\/8400356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":141,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,12,22]]},"published-print":{"date-parts":[[2026,6,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaf272","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2025,12,22]]}}}